PuSH - Publikationsserver des Helmholtz Zentrums München

Lichtmannegger, J. ; Leitzinger, C. ; Wimmer, R.* ; Schmitt, S. ; Schulz, S. ; Kabiri, Y. ; Eberhagen, C. ; Rieder, T.* ; Janik, D. ; Neff, F. ; Straub, B.K.* ; Schirmacher, P.* ; DiSpirito, A.A.* ; Bandow, N.* ; Baral, B.S.* ; Flatley, A. ; Kremmer, E. ; Denk, G.U.* ; Reiter, F.P.* ; Hohenester, S.* ; Eckardt-Schupp, F. ; Dencher, N.A.* ; Adamski, J. ; Sauer, V.* ; Niemietz, C.* ; Schmidt, H.H.* ; Merle, U.* ; Gotthardt, D.N.* ; Kroemer, G.* ; Weiss, K.H.* ; Zischka, H.

Methanobactin reverses acute liver failure in a rat model of Wilson disease.

J. Clin. Invest. 126, 2721-2735 (2016)
Verlagsversion DOI PMC
Free by publisher
Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
In Wilson disease (WD), functional loss of ATPase copper-transporting β (ATP7B) impairs biliary copper excretion, leading to excessive copper accumulation in the liver and fulminant hepatitis. Current US Food and Drug Administration- and European Medicines Agency-approved pharmacological treatments usually fail to restore copper homeostasis in patients with WD who have progressed to acute liver failure, leaving liver transplantation as the only viable treatment option. Here, we investigated the therapeutic utility of methanobactin (MB), a peptide produced by Methylosinus trichosporium OB3b, which has an exceptionally high affinity for copper. We demonstrated that ATP7B-deficient rats recapitulate WD-associated phenotypes, including hepatic copper accumulation, liver damage, and mitochondrial impairment. Short-term treatment of these rats with MB efficiently reversed mitochondrial impairment and liver damage in the acute stages of liver copper accumulation compared with that seen in untreated ATP7B-deficient rats. This beneficial effect was associated with depletion of copper from hepatocyte mitochondria. Moreover, MB treatment prevented hepatocyte death, subsequent liver failure, and death in the rodent model. These results suggest that MB has potential as a therapeutic agent for the treatment of acute WD.
Altmetric
Weitere Metriken?
[➜Einloggen]
Zusatzinfos bearbeiten [➜Einloggen]
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Korrespondenzautor
Schlagwörter Methylosinus-trichosporium Ob3b; Methane-oxidizing Bacteria; D-penicillamine Prevents; Permeability Transition; Copper-acquisition; Cinnamon Rats; Gene-therapy; Mitochondrial; Transplantation; Cells
ISSN (print) / ISBN 0021-9738
e-ISSN 1558-8238
Zeitschrift Journal of Clinical Investigation
Quellenangaben Band: 126, Heft: 7, Seiten: 2721-2735 Artikelnummer: , Supplement: ,
Verlag American Society of Clinical Investigation
Verlagsort Ann Arbor
Nichtpatentliteratur Publikationen
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Molecular Toxicology and Pharmacology (TOXI)
Molekulare Endokrinologie und Metabolismus (MEM)
Institute of Pathology (PATH)
Institute of Molecular Immunology (IMI)
Institute of Radiation Biology (ISB)